Europe — EMA

Onivyde Pegylated Liposomal (Irinotecan)

Irinotecan, the active ingredient in Onivyde, is a Cam Cam presented as a 100 mg/50 ml vial for intravenous use. It treats metastatic colorectal cancer in adult patients.

Irinotecan

Request sourcing

Pack/s

What is Irinotecan?

Irinotecan, the active ingredient in Onivyde, is a Cam Cam presented as a 100 mg/50 ml vial for intravenous use. It treats metastatic colorectal cancer in adult patients. GNH USA supplies Onivyde as a licensed, GDP‑compliant international pharmaceutical supplier serving oncology centres worldwide.

GNH USA supplies Onivyde as a licensed, GDP‑compliant international pharmaceutical supplier serving oncology centres worldwide.

What is Irinotecan used for?

Onivyde is a liposomal irinotecan formulation that ... ... ...

- C ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...

What are the side effects of Irinotecan?

Common ....

Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Send a sourcing enquiry for this product →